Computer-based analysis of doctors’ notes within healthcare records could dramatically speed up the diagnosis of rare diseases, such as…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The AADC Family Network will host its annual AADC Awareness Day event this Thursday, once again seeking to raise…
A new analysis makes a case for the value of Kebilidi (eladocagene exuparvovec-tneq), the first gene therapy approved for…
Researchers have developed a new sensor to detect dopamine, which may be a useful tool for diagnosing and treating neurological…
A new study reports that aromatic L-amino acid decarboxylase (AADC) deficiency was the most common neurotransmitter disorder seen at…
People affected by rare diseases like aromatic L-amino acid decarboxylase (AADC) deficiency require more than just medical support: These…
Doctors at Boston Children’s Hospital say the gene therapy Kebilidi (eladocagene exuparvovec-tneq) can be life-changing for people with…
Ambry Genetics‘ Patient for Life program — designed to systematically reanalyze genetic data as new information becomes available —…
Scientists created a new cell model of AADC deficiency that has allowed them to understand exactly how two disease-causing…
Telerare Health is now offering virtual genomic consultations to people in Minnesota, with the aim of helping those…